Clinical trials
Phase 2/3 Myocardial Infarction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 4 |
| 2011 | 1 |
| 2017 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 6 |
| Terminated | 5 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shahid Beheshti University of Medical Sciences | 2 |
| University of Alberta | 2 |
| ARYx Therapeutics | 1 |
| Affiliated Hospital of North Sichuan Medical College | 1 |
| Bioheart, Inc. | 1 |
| CSL Behring | 1 |
| Catholic University of the Sacred Heart | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| German Heart Institute | 1 |
| Hospices Civils de Lyon | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Infarction | 32 |
| Stroke | 4 |
| Coronary Artery Disease | 3 |
| Diabetes Mellitus | 3 |
| Heart Failure | 3 |
| Myocardial Ischemia | 3 |
| ST Elevation Myocardial Infarction | 3 |
| Angina Pectoris | 2 |
| Angina, Stable | 2 |
| Atherosclerosis | 2 |
Trials
Showing 76 to 32 of 32. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.